1-(4-((4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)methyl)benzyl)-3-(3,4-dihydroxyphenethyl)urea

ID: ALA4858508

Chembl Id: CHEMBL4858508

PubChem CID: 163323742

Max Phase: Preclinical

Molecular Formula: C31H34N6O3

Molecular Weight: 538.65

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCc1nc2c(N)nc3ccccc3c2n1Cc1ccc(CNC(=O)NCCc2ccc(O)c(O)c2)cc1

Standard InChI:  InChI=1S/C31H34N6O3/c1-2-3-8-27-36-28-29(23-6-4-5-7-24(23)35-30(28)32)37(27)19-22-11-9-21(10-12-22)18-34-31(40)33-16-15-20-13-14-25(38)26(39)17-20/h4-7,9-14,17,38-39H,2-3,8,15-16,18-19H2,1H3,(H2,32,35)(H2,33,34,40)

Standard InChI Key:  XIUYQOKKDQPUCV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4858508

    ---

Associated Targets(non-human)

Tlr7 TLR7 and TLR8 (70 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 538.65Molecular Weight (Monoisotopic): 538.2692AlogP: 5.01#Rotatable Bonds: 10
Polar Surface Area: 138.32Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.29CX Basic pKa: 4.87CX LogP: 5.08CX LogD: 5.08
Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.16Np Likeness Score: -0.75

References

1. Kimani FW, Manna S, Moser B, Shen J, Nihesh N, Esser-Kahn AP..  (2021)  Improving the Adjuvanticity of Small Molecule Immune Potentiators Using Covalently Linked NF-κB Modulators.,  12  (9.0): [PMID:34527180] [10.1021/acsmedchemlett.1c00267]

Source